[1.1 Voluntary Disclosure, dated December 27, 2017 A-1 our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; our operations and prospects; our network expansion and capital expenditure plans; the expected imp]
[1.1 Voluntary Disclosure, dated December 27, 2017 A-1 our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; our operations and prospects; our network expansion and capital expenditure plans; the expected imp]
[China Xiniya Fashion Limited Announces Listing Approval by NYSE American XIAMEN, FUJIAN, China—December 28, 2017—China Xiniya Fashion Limited (“Xiniya” or the “Company” NYSE:XNY), announced today that it has received approval from NYSE American LLC (“NYSE American”) to list its American Depositary S]
[China Xiniya Fashion Limited Announces Listing Approval by NYSE American XIAMEN, FUJIAN, China—December 28, 2017—China Xiniya Fashion Limited (“Xiniya” or the “Company” NYSE:XNY), announced today that it has received approval from NYSE American LLC (“NYSE American”) to list its American Depositary S]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 ANNOUNCEMENT: CONNECTED TRANSACTION ACQUISITION OF 100% EQUITY INTERESTS IN QINGDAO LIGHT METAL Aluminum Corporation of China Limited Date December 28, 2017 By]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 ANNOUNCEMENT: CONNECTED TRANSACTION ACQUISITION OF 100% EQUITY INTERESTS IN QINGDAO LIGHT METAL Aluminum Corporation of China Limited Date December 28, 2017 By]
[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): December 28, 2017 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identificati]
[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): December 28, 2017 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identificati]
[] [Manatt, Phelps & Phillips, LLP December 28, 2017 Highpower International, Inc. Building A1, Luoshan Industrial Zone, Shanxia, Pinghu, Longgang, Shenzhen, Guangdong, 518111 People’s Republic of China Re: Registration Statement on Form S-8 Ladies and Gentlemen: Registration Statement Company Commis]
[] [Manatt, Phelps & Phillips, LLP December 28, 2017 Highpower International, Inc. Building A1, Luoshan Industrial Zone, Shanxia, Pinghu, Longgang, Shenzhen, Guangdong, 518111 People’s Republic of China Re: Registration Statement on Form S-8 Ladies and Gentlemen: Registration Statement Company Commis]
